PPRD1, along with PPRD2, belongs to the polyprenol reductase family. These enzymes convert polyprenols (Prens) to dolichols (Dols) via α-saturation, a process critical for endoplasmic reticulum (ER)-mediated protein glycosylation . Key features include:
PPRD1 contains five transmembrane domains and shares 47–54% similarity with human SRD5A3, a homolog involved in congenital glycosylation disorders . Alternative splicing generates variants (e.g., PPRD1-INT3, PPRD1-INT4), though their functional relevance remains unclear .
In vitro assays: Recombinant PPRD1 reduces Pren-16 to Dol-16 at ~11% efficiency, compared to PPRD2’s 30% .
Complementation studies: PPRD1 overexpression rescues pprd2 knockout lethality in Arabidopsis, restoring dolichol synthesis and viability .
Knockout phenotypes:
Temporal regulation: PPRD1 expression rises in roots but declines in leaves with age, while PPRD2 remains stable .
Tissue specificity: PPRD2 is exclusively expressed in pollen, whereas PPRD1 is absent .
PPRD1’s role in dolichol biosynthesis links it to:
ER stress mitigation: pprd2 PPRD1-OE plants show elevated BiP2 protein levels, indicating unresolved ER stress despite viability .
Reproductive development: PPRD2 deficiency disrupts pollen tube elongation, highlighting dolichol-dependent glycosylation in gametogenesis .
Biochemical characterization: Structural studies to define catalytic mechanisms.
Agricultural applications: Engineering PPRD1 overexpression to enhance stress tolerance in crops.